Hypothalamic-Pituitary-Adrenocortical (HPA) Axis Response and Biotransformation of Oral Naltrexone: Preliminary Examination of Relationship to Family History of Alcoholism

被引:0
作者
Andrea C King
James Schluger
Mithat Gunduz
Lisa Borg
Guillaume Perret
Ann Ho
Mary Jeanne Kreek
机构
[1] University of Chicago,Department of Psychiatry
[2] Rockefeller University,undefined
[3] Laboratory of the Biology of Addictions,undefined
来源
Neuropsychopharmacology | 2002年 / 26卷
关键词
Naltrexone; 6-β-naltrexol; Opioid antagonist; HPA axis; ACTH; Cortisol;
D O I
暂无
中图分类号
学科分类号
摘要
We examined HPA axis response to 50 mg oral naltrexone compared with placebo in 17 healthy male and female nonalcoholic subjects, approximately half of whom had a positive family history of alcoholism (FH+) and half of whom who did not (FH−). Mood response and naltrexone biotransformation were also examined at various intervals. Subjects participated in two morning test sessions (50 mg naltrexone or identical placebo pill) after an overnight stay in the Rockefeller University GCRC. For the total sample, ACTH and cortisol significantly increased after naltrexone compared with placebo (p < .05). Secondary analyses showed the FH+ subgroup had a different pattern of response over time compared with the FH− subgroup, with heightened ACTH and cortisol, and decreased vigor ratings, during naltrexone (p < .05). The results demonstrate that orally administered naltrexone acutely disinhibits the HPA axis, and that individuals with an assumed greater biological vulnerability to addiction, by virtue of familial alcoholism, had altered regulation of the HPA axis in part under the control of the endogenous opioid system. 166 words.
引用
收藏
页码:778 / 788
页数:10
相关论文
共 243 条
[1]  
Anton RF(1999)Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial Am J Psychiatry 156 1758-1764
[2]  
Moak DH(1995)Development and initial validation of a measure of drinking urges in abstinent alcoholics Alcohol Clin Exp Res 19 600-606
[3]  
Waid LR(1998)Single nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: Possible implications for opiate addiction Proc Natl Acad Sci 95 9608-9613
[4]  
Latham PK(1983)High-dose naloxone infusion in normals Arch Gen Psychiatry 40 613-619
[5]  
Malcolm RJ(1985)Effect of naloxone on the hormone response to CRF in normal man Endocr Res 11 39-44
[6]  
Dias JK(1974)The urinary excretion profiles of naltrexone in man Drug Metab Dispos 2 506-512
[7]  
Bohn MJ(1996)Naltrexone increases the latency to drink alcohol in social drinkers Alcoholism: Clinical and Experimental Research 20 732-739
[8]  
Krahn DD(1994)Opioid peptide and α-adrenoceptor pathways in the regulation of the pituitary-adrenal axis in man J Endocrinol 141 163-168
[9]  
Staehler BA(1984)Detecting alcoholism: The CAGE questionnaire JAMA 252 1905-1907
[10]  
Bond C(1999)Variable dose naltrexone-induced hypothalamic-pituitary-adrenal stimulation in abstinent alcoholics: A preliminary study Alcohol Clin Exp Res 23 502-508